Hemoglobin (Hb) monitoring in patients undergoing home therapies is fundamental to increase overall quality of life and to prevent pathologies such as anemia, which may further exacerbate the overall clinical situation. The gene discussed is GSTM1; the disease is anemia (phenotype).